Technology

Posters

Poster presented to ESMO 2022 Annual Meeting

Open-label, dose-escalation, phase I/II study to assess the safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-Programmed Death-1 (PD-1) treatment in patients with non-small-cell lung cancer (NSCLC).
J. Vansteenkiste, I. Demedts, E. Pons-Tostivint, B. Biesma, F. Borm, B. Colinet, K. Cuppens, S. Derijcke, L. Greillier, J. Jurgens, D. Moro-Sibilot, M. Pérol, M. Sebastian, M. Skrzypski, W. Theelen, C. Van De Kerkhove, M. Collodoro, J. Plumas, C. Debruyne, A. Sibille

Presented September 12, 2022
Check the document

 

eTalk given to the 18th CIMT Annual Meeting

Priming and expansion of functional antitumor T-cells in melanoma patients: results of phase I clinical trial with GeniusVac-Mel4, an innovative cancer vaccine based on a plasmacytoid dendritic cell line.
J. Charles, L. Chaperot, D. Hannani, J. Bruder Costa, I. Templier, S. Trabelsi, H. Gil, A. Moisan, V. Persoons, H. Hegelhofer, E. Schir, J.-L. Quesada, C. Mendoza, C. Aspord, O. Manches, P. Coulie, A. Khammari, B. Dreno, M.-T. Leccia, J. Plumas.

Presented: May 10-12, 2022
Check the document

 

eTalk given to the 18th CIMT Annual Meeting

The retroviral engineering of a human plasmacytoid dendritic cell-based vaccine allowed the priming and expansion of multispecific viral and tumor antigen-specific T-cells in multiple HLA contexts.
K. Lenogue, A. Walencik, K. Laulagnier, J.-P. Molens, H. Benlalam, B. Dreno, P. Coulie, M. Pule, L. Chaperot, J. Plumas

Presented: May 10-12, 2022
Check the document

 

Poster presented to European Lung Cancer Virtual Congress (ELCC 2021 Virtual)

An open-label, dose escalation, Phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-Programmed Death-1 (PD-1) treatment in patients with Non-small cell lung cancer (NSCLC).
J. Bennouna, A. Sibille, C. Debruyne, B. Colinet, I. Demedts, S. Derijcke, L. Greillier, J. Jurgens, H. Lena, D. Moro-Sibilot, M. Pérol, X. Quantin, N. Reinmuth, M. Sebastian, M. Genin, J. Plumas, J. Vansteenkiste

Presented: March 25 – 27, 2021
Check the document

 

Poster presented to ESMO Immuno Oncology Congress 2017

Priming and expansion of neo-antigen specific-T cells thanks to an off-the-self cell-based drug product.
Plumas J, De Sousa Alves PM, Leplus E, Chaperot L, Hannani D

December 7-10, 2017
Check the document